CannAssist International Corp. (CNSC) Sees Product Popularity Grow as Professional Athletes Switch to CBD for Pain Relief

February 19, 2021 10:48:01
  • CBD-based products have become increasingly popular among professional athletes, primarily due to pain-relieving, anti-inflammatory qualities
  • CannAssist International’s Xceptor Labs is an active player within the CBD-based product sector through the development of its proprietary CiBiDinol technology
  • CiBiDinol’s technology, using a water-soluble carrier, developed an encapsulation process to deliver unchanged CBD molecule through cell’s watery matrix
  • Xceptor Labs has seen rapid uptake in products’ popularity, with ten products now available for sale online

When three-time National Football League tight end Rob Gronkowski first announced his retirement from professional football, he attributed part of the decision to the heavy toll that injuries and nine subsequent surgeries had had on his ravaged body. However, the use of cannabidiol (“CBD”)-based topical pain relief products and the significant benefit provided by these played a large part in influencing the Super Bowl-winning athlete to return to the professional sports arena. CannAssist International (OTCQB: CNSC), a biotechnological pharmaceutical company and owner of Xceptor Labs, has sought to capitalize on the growing prominence CBD-based products within professional sports through its innovative technology and proprietary product portfolio.

The chronic use of over-the-counter pain relievers (i.e., nonsteroidal anti-inflammatory drugs or NSAIDs) and opioids are widely documented as posing more significant health risks previously known, with opioid addictions leading to the deaths of thousands of Americans annually. In such a landscape, professional athletes have been eager to learn about the pain relief and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.